Affiliation:
1. 大阪医科薬科大学 関西 BNCT 共同医療センター
2. 大阪医科薬科大学 耳鼻咽喉科頭頸部外科
Publisher
Oto-Rhino-Laryngological Society of Japan, Inc.
Reference9 articles.
1. 1) Mishima Y: Neutron capture treatment of malignant melanoma using 10B-chlorpromazine compound. Pigment Cell Res 1973; 1: 215-221.
2. 2) Mishima Y: Melanoma and nonmelanoma neutron capture therapy using gene therapy: overview. In advances in neutron capture therapy. Larsson B, Crawford J, Weinreich R eds: Elsevier Science, Amsterdam 1997; 10-25.
3. 3) Kato I, Ono K, Sakurai Y, et al: Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 2004; 61: 1069-1073.
4. 4) Hirose K, Konno A, Hiratsuka J, et al: Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): an open-label phase II trial. Radiother Oncol 2021; 155: 182-187.
5. 5) 森田倫正, 粟飯原輝人, 平塚純一, 他: 鼻副鼻腔悪性黒色腫に対するホウ素熱中性子捕捉療法の治療効果. 臨床放射線 2010; 55: 1009-1017.